Conley Susanne B, Buckley Paula, Magarace Lisa, Hsieh Candace, Pedulla Lillian Vitale
Dana-Farber Cancer Institute, Boston, Massachusetts, and Brigham and Women's Hospital, Boston, Massachusetts. Susanne B. Conley, MSN, RN, CPON, AOCNS®, is an advanced oncology clinical nurse specialist at Dana-Farber Cancer Institute in Boston, Massachusetts, with more than 35 years of clinical, administrative, and educational experience. Ms Conley is responsible for oversight and development of nursing policies and procedures assuring compliance with current practice and regulatory agency requirements. As a clinical nurse specialist for several oncology specialty practices, she is responsible for assuring evidence-based practice and staff training. Ms Conley is active in national organizations and has served as a project team member for the Oncology Nursing Society Institute for Evidence-Based Practice Change. She has published articles and developed curricula on nursing practice, and has spoken extensively on nursing practice issues. Paula Buckley, BSN, RN, is an intravenous (IV) access nurse at Dana-Farber Cancer Institute in Boston. She serves on the venous access committee and precepts new RN staff with IV skills. Lisa Magarace, BSN, RN, is an IV and apheresis specialist and served for 2 years as the full-time charge nurse on the laboratory services unit at Dana-Farber Cancer Institute. Candace Hsieh, BSN, RN, CIC®, is an infection control nurse specialist. She works for the infection control department of both Brigham and Women's Hospital and Dana-Farber Cancer Institute, where she also works in the pediatric oncology department. She oversees surveillance and monitoring of central line-associated bloodstream infections. She also serves on the venous access, infection control, and nursing policy and procedure committees. Lillian Vitale Pedulla, MSN, BSN, RN, NEA-BC, served as the director of laboratory services, developing the nurse IV access team for Dana-Farber Cancer Institute. She served on the adult nursing practice, venous access, and nursing policy and procedure committees.
J Infus Nurs. 2017 May/Jun;40(3):165-174. doi: 10.1097/NAN.0000000000000217.
Nearly 3 million central vascular access devices (CVADs) are used in the United States each year. These devices are an important advance in health care and essential to oncology patients. However, CVADs are the most frequent cause of central line-associated bloodstream infections (CLABSIs). CLABSI can be prevented when evidence-based practices are followed consistently over time. Professional organizations establish valid standards and guidelines to guide CVAD practice. This article identifies strategies implemented at a comprehensive ambulatory cancer center to integrate professional evidence-based standards and guidelines for implanted port care into nursing practice at the point of care.
在美国，每年有近300万个中心血管通路装置（CVAD）被使用。这些装置是医疗保健领域的一项重要进展，对肿瘤患者至关重要。然而，CVAD是中心静脉导管相关血流感染（CLABSI）最常见的原因。如果长期持续遵循循证实践，CLABSI是可以预防的。专业组织制定有效的标准和指南来指导CVAD的操作。本文确定了一个综合性门诊癌症中心实施的策略，以便将植入式端口护理的专业循证标准和指南融入到护理实践中的护理点。
